Quantcast
Last updated on April 16, 2014 at 6:04 EDT

BioClinica Releases Integrated Medical Image Management Solution

April 16, 2013

- BioClinica WebSend Improves Imaging Data Quality and Availability for Clinical Trials -

NEWTOWN, Pa., April 16, 2013 /PRNewswire/ — BioClinica(®), Inc., a global provider of clinical trial management services, announced today the newest release of WebSend, the company’s industry-leading medical image submission technology for clinical trials.

(Logo: http://photos.prnewswire.com/prnh/20130403/PH87647LOGO)

BioClinica WebSend is an electronic data transfer solution that offers significant value over other methods to collect and manage medical images for clinical trials. Investigator sites use WebSend to securely transmit medical images for clinical trials over the internet. Pharmaceutical clinical trial sponsors prefer WebSend to outdated alternatives and courier services because it improves the quality of their trial data, makes clinical imaging data immediately available for review, and reduces costs of conducting an imaging-based clinical trial.

The newest version of WebSend offers many capabilities that improve data quality and reduce cost:

  • Protected Health Information (both meta-data and pixel data) is removed prior to image submission
  • Protocol deviations are fully documented before images leave the investigator site.
  • Both DICOM and non-DICOM image data is supported through one system
  • Browser-based DICOM viewer for both web-submitted and couriered images
  • 100% integration with BioPACS, BioClinica’s image management system, which eliminates manual data entry and ensures data quality

“Electronic image submission is the best way to ensure data quality and reduce the cost of imaging-based clinical trials,” said Mark Weinstein, CEO of BioClinica, “and WebSend is the clear choice to meet these goals.” “When an image is uploaded via WebSend, it automatically becomes part of BioClinica’s integrated image management and independent review system. There are no manual steps, data entries, or transfers required. Best of all, sponsors have immediate access to their images through BioClinica’s secure web portal.”

In addition to advantages for trial sponsors, WebSend also makes participation in imaging-based clinical trials easier for investigator sites. WebSend provides a single point of contact for sites with an easy-to-use interface for uploading images. It features a “To-Do” task list that leads users through the upload process and helps reduces errors. Also, WebSend utilizes advanced technology to speed up transfer times and allow multiple images to be uploaded simultaneously.

Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on twitter at http://twitter.com/bioclinica.

About BioClinica, Inc.

BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. A 2013 merger with CoreLab Partners has created a new standard in imaging core lab services including electronic transfer, management, and independent review; cardiovascular safety monitoring including automated ECG, Thorough QT studies, Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis; and eClinical solutions for electronic data capture, randomization, clinical trial management, and clinical supply chain forecasting and optimization. BioClinica offers unmatched scientific expertise with a team of respected medical researchers and board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. With more than 28 years of experience and over 3300 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide comprehensive cardiovascular safety, and eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.

SOURCE BioClinica, Inc.


Source: PR Newswire